Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5605-5610, October 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larsson, O.
Right arrow Articles by Wejde, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larsson, O.
Right arrow Articles by Wejde, J.

Abolition of Mevinolin-induced Growth Inhibition in Human Fibroblasts following Transformation by Simian Virus 401

O. Larsson2, C. Barrios, C. Latham, J. Ruiz, A. Zetterberg, P. Zickert and J. Wejde

Department of Tumor Pathology, Karolinska Institutet, S-104 01 Stockholm, Sweden

The basal level of the gene expression and the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase was higher in SV40-transformed human fibroblasts (90-VA VI) than in normal ones (HDF). In both these cell types mevinolin (25 µM) caused an 85–90% depression of HMG CoA reductase activity and of the incorporation of [3H]acetate into sterols. In HDF this was coupled to an efficient block of cell growth, whereas the growth of 90-VA VI was only slightly reduced by mevinolin. In HDF, mevinolin (25 µM) also abolished essentially all dolichol synthesis, as measured by incorporation of [3H]acetate. In contrast, dolichol synthesis remained unaltered, or was increased, in mevinolin-treated 90-VA VI. We suggest that these different responses of dolichol synthesis may depend on different substrate affinities of the rate-limiting enzyme in the dolichol pathway. However, if 90-VA VI was treated with 25-hydroxycholesterol (25-OH), an alternative inhibitor of HMG CoA reductase, the cellular growth as well as dolichol synthesis was significantly decreased. Since the inhibitory effect of 25-OH on HMG CoA reductase activity did not exceed that of mevinolin, it seems that 25-OH, besides inhibiting HMG CoA reductase, inhibits steps distal to HMG CoA reductase. This notion was further supported by the finding that addition of mevalonate did not prevent the 25-OH-induced growth inhibition. However, if dolichol was added along with 25-OH, the block was partially prevented, indicating that a critical level of de novo synthesis of dolichol is essential for cellular growth.

1 This work was supported by grants from the Swedish Cancer Society and the Stockholm Cancer Society and by the Research Funds of the Karolinska Institute.

2 To whom requests for reprints should be addressed.

Received 7/19/88. Revised 5/23/89. Accepted 7/20/89.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Rao, D. C. Porter, X. Chen, T. Herliczek, M. Lowe, and K. Keyomarsi
Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase
PNAS, July 6, 1999; 96(14): 7797 - 7802.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Essig, G. Nguyen, D. Prie, B. Escoubet, J.-D. Sraer, and G. Friedlander
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Increase Fibrinolytic Activity in Rat Aortic Endothelial Cells : Role of Geranylgeranylation and Rho Proteins
Circ. Res., October 5, 1998; 83(7): 683 - 690.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.